Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.

Authors:
Qiu X; He H; Zeng H; Tong X; Zhang C and 3 more

Journal:
Genes Dis

Publication Year: 2023

DOI:
10.1016/j.gendis.2023.04.035

PMCID:
PMC10825309

PMID:
38292182

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Genes Dis

Abbreviation: Genes Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fib…
Xu Z; Davies ER; Yao L and 11 more (2024) - Transparency Score: 4/6
Advances in oral mesenchymal stem cell-derived extracellular vesicles in health and disease.
Luo H; Birjandi AA; Ren F and 4 more (2023) - Transparency Score: 3/6
A <i>BBS4</i> mutation causes autosomal dominant polycystic liver disease.
Cui Y; Xu W; Liu J and 6 more (2023) - Transparency Score: 3/6
An analysis of the transcriptional landscape in hypoxia-treated primary nucleus pulposus cells.
Peng Z; Wang Z; Guo S and 7 more (2023) - Transparency Score: 3/6
A novel preimplantation genetic testing strategy for a subtelomeric genetic disorder: A case study.
Chen S; Wang L; Chen L and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding This work was supported by Changsha Natural Science Foundation, Hunan, China (No. kq2202382), the Natural Science Foundation of Hunan, China (No. 2022JJ40802, 2022JJ30928), and the Project funded by 10.13039/501100002858China Postdoctoral Science Foundation (No. 2022M713525)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025